Epstein Barr Virus Infection Affects Function of Cytotoxic T Lymphocytes in Patients with Severe Aplastic Anemia

被引:7
作者
Zhang, Tian [1 ]
Liu, Chunyan [1 ]
Liu, Hui [1 ]
Li, Lijuan [1 ]
Wang, Ting [1 ]
Fu, Rong [1 ]
机构
[1] Tianjin Med Univ, Dept Hematol, Gen Hosp, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
CELLS; PATHOGENESIS; DIAGNOSIS; PROGNOSIS; GLOBULIN; THERAPY; EBNA1; EBV;
D O I
10.1155/2018/6413815
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Severe aplastic anemia (SAA) is characterized by pancytopenia and failure of hematopoietic function and is caused by excessive functioning of cytotoxic T lymphocytes (CTLs). EBNA-1, a nucleoprotein of the Epstein Barr virus (EBV), can influence the proliferation and function of lymphocytes. We therefore tested the number of EBV copies in the CDS + T cells of 27 patients with SAA and 10 healthy control subjects and observed the influences of EBNA-1 upon the CD8+ T cells of patients with SAA. The results showed that more EBV copies were found in the CD8+ T cells of patients with untreated SAA than in patients with SAA in remission or in the healthy control subjects. Their copy number was positively correlated with the expression of granzyme B and perforin, the secretion level of interferon-y in CD8+ T cells, and the viability of CD8+T cells, whereas no correlation was seen between the copy number and the interleukin 4 secretion level or the apoptosis rate. Meanwhile, the expression of granzyme B and perforin was reduced after EBNA-1 gene knockdown, whereas the interferon-y secretion level and cell viability declined. Therefore, we infer that EBV infection may be a factor in the activation of CTLs and in damaging the bone marrow hematopoietic function of patients with SAA.
引用
收藏
页数:10
相关论文
共 31 条
[21]   Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival [J].
Tempera, Italo ;
De Leo, Alessandra ;
Kossenkov, Andrew V. ;
Cesaroni, Matteo ;
Song, Hui ;
Dawany, Noor ;
Showe, Louise ;
Lu, Fang ;
Wikramasinghe, Priyankara ;
Lieberman, Paul M. .
JOURNAL OF VIROLOGY, 2016, 90 (01) :345-355
[22]   Epstein-Barr virus infection-induced inflammasome activation in human monocytes [J].
Torii, Yuka ;
Kawada, Jun-ichi ;
Murata, Takayuki ;
Yoshiyama, Hironori ;
Kimura, Hiroshi ;
Ito, Yoshinori .
PLOS ONE, 2017, 12 (04)
[23]   Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation [J].
Valentine, Robert ;
Dawson, Christopher W. ;
Hu, Chunfang ;
Shah, Khilan M. ;
Owen, Thomas J. ;
Date, Kathryn L. ;
Maia, Sonia P. ;
Shao, Jianyong ;
Arrand, John R. ;
Young, Lawrence S. ;
O'Neil, John D. .
MOLECULAR CANCER, 2010, 9
[24]   Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism [J].
Wang, Chao ;
Wang, Huan ;
Zhang, Yaqian ;
Guo, Wei ;
Long, Cong ;
Wang, Jingchao ;
Liu, Limei ;
Sun, Xiaoping .
ONCOLOGY REPORTS, 2017, 37 (04) :2109-2120
[25]   The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China [J].
Wang, Huaquan ;
Tu, Meifeng ;
Fu, Rong ;
Wu, Yuhong ;
Liu, Hong ;
Xing, Limin ;
Shao, Zonghong .
PLOS ONE, 2014, 9 (05)
[26]  
WEINBLATT ME, 1991, AM J PEDIAT HEMATOL, V13, P465
[27]   Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways [J].
Wood, V. H. J. ;
O'Neil, J. D. ;
Wei, W. ;
Stewart, S. E. ;
Dawson, C. W. ;
Young, L. S. .
ONCOGENE, 2007, 26 (28) :4135-4147
[28]   CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia [J].
Xing, Limin ;
Liu, Chunyan ;
Fu, Rong ;
Wang, Huaquan ;
Wang, Jun ;
Liu, Xiao ;
Feng, Le ;
Li, Lijuan ;
Liu, Hui ;
Wang, Honglei ;
Zhang, Tian ;
Shao, Zonghong .
MOLECULAR MEDICINE REPORTS, 2014, 10 (03) :1252-1258
[29]  
Xinhong Q., 1998, ZHONGHUAXUE YE XUEZA, V20, P540
[30]   Aplastic anemia [J].
Young, Neal S. ;
Scheinberg, Phillip ;
Calado, Rodrigo T. .
CURRENT OPINION IN HEMATOLOGY, 2008, 15 (03) :162-168